Proteins > Fatty acid-binding protein, adipocyte
Page last updated: 2024-08-07 13:01:12
Fatty acid-binding protein, adipocyte
A fatty acid-binding protein, adipocyte that is encoded in the genome of human. [PRO:DNx, UniProtKB:P15090]
Synonyms
Adipocyte lipid-binding protein;
ALBP;
Adipocyte-type fatty acid-binding protein;
A-FABP;
AFABP;
Fatty acid-binding protein 4
Research
Bioassay Publications (13)
| Timeframe | Studies on this Protein(%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
Compounds (11)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP).Bioorganic & medicinal chemistry letters, , Jun-15, Volume: 17, Issue:12, 2007
Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.Bioorganic & medicinal chemistry letters, , Sep-06, Volume: 14, Issue:17, 2004
Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 1. Models without explicit constrained water.Journal of medicinal chemistry, , Jun-06, Volume: 45, Issue:12, 2002
Fragment-to-Lead Medicinal Chemistry Publications in 2020.Journal of medicinal chemistry, , 01-13, Volume: 65, Issue:1, 2022
Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation.Journal of medicinal chemistry, , 04-23, Volume: 63, Issue:8, 2020
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022.European journal of medicinal chemistry, , Oct-05, Volume: 240, 2022
Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 1. Models without explicit constrained water.Journal of medicinal chemistry, , Jun-06, Volume: 45, Issue:12, 2002
The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biological evaluation.Bioorganic & medicinal chemistry, , 09-15, Volume: 24, Issue:18, 2016
Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening.Bioorganic & medicinal chemistry letters, , Jun-15, Volume: 20, Issue:12, 2010
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP).Bioorganic & medicinal chemistry letters, , Jun-15, Volume: 17, Issue:12, 2007
The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biological evaluation.Bioorganic & medicinal chemistry, , 09-15, Volume: 24, Issue:18, 2016
Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination.European journal of medicinal chemistry, , Jan-27, Volume: 90, 2015
Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening.Bioorganic & medicinal chemistry letters, , Jun-15, Volume: 20, Issue:12, 2010
Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation.Journal of medicinal chemistry, , 04-23, Volume: 63, Issue:8, 2020
Interaction Analysis of FABP4 Inhibitors by X-ray Crystallography and Fragment Molecular Orbital Analysis.ACS medicinal chemistry letters, , Apr-14, Volume: 7, Issue:4, 2016
The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biological evaluation.Bioorganic & medicinal chemistry, , 09-15, Volume: 24, Issue:18, 2016
Structure-guided design, synthesis and in vitro evaluation of a series of pyrazole-based fatty acid binding protein (FABP) 3 ligands.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 23, Issue:6, 2013
New aromatic substituted pyrazoles as selective inhibitors of human adipocyte fatty acid-binding protein.Bioorganic & medicinal chemistry letters, , May-15, Volume: 21, Issue:10, 2011
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP).Bioorganic & medicinal chemistry letters, , Jun-15, Volume: 17, Issue:12, 2007
Enables
This protein enables 4 target(s):
| Target | Category | Definition |
|---|
| long-chain fatty acid transmembrane transporter activity | molecular function | Enables the transfer of a long-chain fatty acid from one side of a membrane to the other. A long-chain fatty acid has an aliphatic tail containing 13 to 22 carbons. [ISBN:0198506732] |
| long-chain fatty acid binding | molecular function | Binding to a long-chain fatty acid. A long-chain fatty acid has an aliphatic tail containing 13 to 22 carbons. [GOC:pm, PMID:12641450] |
| hormone receptor binding | molecular function | Binding to a receptor for a hormone. [GOC:ai] |
| fatty acid binding | molecular function | Binding to a fatty acid, an aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis. [ISBN:0198506732] |
Located In
This protein is located in 5 target(s):
| Target | Category | Definition |
|---|
| nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
| cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
| lipid droplet | cellular component | An intracellular non-membrane-bounded organelle comprising a matrix of coalesced lipids surrounded by a phospholipid monolayer. May include associated proteins. [GOC:mah, GOC:tb] |
| cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
| extracellular exosome | cellular component | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. [GOC:BHF, GOC:mah, GOC:vesicles, PMID:15908444, PMID:17641064, PMID:19442504, PMID:19498381, PMID:22418571, PMID:24009894] |
Active In
This protein is active in 2 target(s):
| Target | Category | Definition |
|---|
| cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
| nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
Involved In
This protein is involved in 11 target(s):
| Target | Category | Definition |
|---|
| response to bacterium | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium. [GOC:hb] |
| long-chain fatty acid transport | biological process | The directed movement of a long-chain fatty acid into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. A long-chain fatty acid has an aliphatic tail containing 13 to 22 carbons. [GOC:ai] |
| cholesterol homeostasis | biological process | Any process involved in the maintenance of an internal steady state of cholesterol within an organism or cell. [GOC:go_curators] |
| negative regulation of DNA-templated transcription | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. [GOC:go_curators, GOC:txnOH] |
| positive regulation of inflammatory response | biological process | Any process that activates or increases the frequency, rate or extent of the inflammatory response. [GOC:ai] |
| white fat cell differentiation | biological process | The process in which a relatively unspecialized cell acquires specialized features of a white adipocyte, an animal connective tissue cell involved in energy storage. White adipocytes have cytoplasmic lipids arranged in a unique vacuole. [PMID:12508945] |
| brown fat cell differentiation | biological process | The process in which a relatively unspecialized cell acquires specialized features of a brown adipocyte, an animal connective tissue cell involved in adaptive thermogenesis. Brown adipocytes contain multiple small droplets of triglycerides and a high number of mitochondria. [PMID:12588810] |
| cellular response to lithium ion | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus. [GOC:mah] |
| cellular response to tumor necrosis factor | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus. [GOC:mah] |
| positive regulation of cold-induced thermogenesis | biological process | Any process that activates or increases the frequency, rate or extent of cold-induced thermogenesis. [PMID:27876809] |
| fatty acid transport | biological process | The directed movement of fatty acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Fatty acids are aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis. [GOC:ai] |